Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
PyroGenesis Signs $725,000 Contract with Global Environmental Services Company
-
Brunswick Exploration Announces 2025 Exploration Plans for Greenland and Stakes Additional Ground Near Paamiut
-
Spectral AI Strengthens Financial Position Ahead of FDA Submission
-
Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
-
Emerita Has Been Granted the “Ontario” Exploration Permit Adjacent to its Iberian Belt West Project; Hosts Several Historic Producing Mines
-
LexisNexis Announces “Top 100 Global Innovators” for 2025, Recognizing Leading Companies Driving Innovation in the Global Economy
-
GXO Adds New ‘Mega Depots’ for Siemens Healthineers in the U.S.
-
Mural Oncology to Present at the TD Cowen 45th Annual Health Care Conference
-
Olema Oncology Appoints Shawnte M. Mitchell, J.D. as Chief Legal Officer and Corporate Secretary
-
CECO Environmental To Release Fourth Quarter Earnings and Host Conference Call on February 25
-
TScan Therapeutics to Participate in the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
-
Baltic Horizon will hold an Investor Conference Webinar to introduce the results for Q1-Q4 2024
-
ECARX Solutions Contribute to Geely’s Record-Breaking Sales in January 2025, Showcasing Scalable, Cost-Effective Solutions
-
Defense and Aerospace Leader Tom Jackson Named New Kymeta Chief Revenue Officer
-
North Star Network acquires leading casino affiliate Bojoko
-
DraftKings Announces Launch of $500 Million Term Loan B Facility
-
Reliance, Inc. Announces Upcoming Conference Participation
-
Alliance Witan PLC - Net Asset Value
-
Solid Biosciences Reports Positive Initial Clinical Data from Next-Generation Duchenne Gene Therapy Candidate SGT-003
-
UgoWork to showcase cutting-edge lithium-ion solutions and industry insights at ProMat 2025
-
American Lamprecht Enhances Visibility for Air and Ocean Shipments Using Descartes Solution
-
Probe Gold Announces Positive Geochemical Results; Confirms Non-Acid-Generating, Non-Leachable Classification for Novador Mine Project Waste Rock and Tailings
-
Teleflex to Present at the Raymond James & Associates 46th Annual Institutional Investors Conference
-
Hyperscale Data Declares Monthly Cash Dividend of $0.2708333 Per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock
-
Teleflex to Present at the Raymond James & Associates 46th Annual Institutional Investors Conference
-
Chart Industries to Participate in Investor Events
-
Enlivex Issues Urgent Statement on Fraudulent News Dissemination
-
Net Asset Value(s)
-
Bitget Releases January 2025 Transparency Report, Showcasing Market Growth and Innovation
-
Beyond, Inc. Executive Chairman Marcus Lemonis to Host Live Event on X Spaces on “How Tokenization Will Monetize Ownership and Provide Cash Flow”
-
Tri Pointe Homes, Inc. Reports 2024 Fourth Quarter And Full Year Results
-
Diamondback Energy, Inc. Announces Midland Basin Acquisition
-
Hesai Group to Report Fourth Quarter and Full Year 2024 Financial Results on Monday, March 10, 2025
-
BlackRock® Canada Announces February Cash Distributions for the iShares® ETFs
-
HighPeak Energy, Inc. Announces Quarterly Dividend
-
Verona Pharma Announces March 2025 Investor Conference Participation
-
Shriners Hospitals for Children Canada Kicks Off Centennial Celebrations with a Special Event for its Local, National and International Community
-
13th Joseph Chung Scholarship Ceremony Recognizes Student Achievement and Legacy of Giving
-
Atsign Unveils First Invisible Cloud on Oracle Cloud Infrastructure
-
Zymeworks Announces Appointment of Oleg Nodelman to Board of Directors
-
AMMO, Inc. Announces Preferred Stock Dividend
-
Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
-
Verona Pharma Announces March 2025 Investor Conference Participation
-
Aktsiaselts Infortar Investor Webinar introducing the results of the Q4 2024
-
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
-
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
-
Ripple: BlocScale Launchpad Reaffirms It’s Mission to Onboard Innovative Projects to XRP – Join Blocscale Private Sale
-
2025 Shenyang Hunnan District Industrial Application Scenarios Release Conference Held with Great Success
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DOWLAIS GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - RENEWI PLC - Ordinary Shares
